title: Percutaneous portal vein thrombolysis and endovascular stent for management of posttransplant portal venous conduit thrombosis.
abstract: BACKGROUND
  Thrombosis of a portal vein conduit after liver transplant is an uncommon clinical situation. Percutaneous thrombolytic therapy for this condition has not been widely described.
  
  
  METHODS
  We describe a case of thrombosis of a portal vein (PV) conduit subsequent to orthotopic liver transplantation that was successfully treated by percutaneous portal vein thrombolysis by using tissue plasminogen activator, angioplasty, and endovascular stent placement.
  
  
  RESULTS
  A satisfactory outcome was achieved with a patent portal vein, on ultrasound, at 8-month follow-up.
  
  
  CONCLUSIONS
  A percutaneous transhepatic approach to treatment of thrombosis of a portal vein conduit appears to be a promising technique to use to avoid surgery, with good medium-term results.
authors.affiliation: Department of Radiodiagnosis, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
authors.forename: T
authors.initials: T
authors.lastname: Bhattacharjya
authors.forename: S P
authors.initials: SP
authors.lastname: Olliff
authors.forename: S
authors.initials: S
authors.lastname: Bhattacharjya
authors.forename: D F
authors.initials: DF
authors.lastname: Mirza
authors.forename: P
authors.initials: P
authors.lastname: McMaster
mesh_terms: D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000379:methods / Q000502:physiology; D008875:Middle Aged; D011169:Portal Vein; D011183:Postoperative Complications / Q000628:therapy*; D015607:Stents; D015912:Thrombolytic Therapy; D013997:Time Factors; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000209:etiology / Q000628:therapy*
chemical_list: D005343:Fibrinolytic Agents; D006493:Heparin